Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of ...

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic ...

Bayer cut its full-year earnings target after a tough agricultural market hit its crop-science division, and said it heads ...

Opinions expressed by Forbes Contributors are their own. Leadership Strategist Dan Pontefract covers leadership and culture. Heike Prinz of Bayer's Board of Management recently articulated the ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.